Tweet
Yeh exactly - & its much easier to get through trials compared to a new drug that needs over 150 million in investments & a ten year study.
-
-
Just got an email from the Replicel newsletter:
That seems like a long time between end of Phase I and beginning of Phase II. They should have started by now.Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013 VANCOUVER, BC – November 7, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) is pleased to report on its pre-filing scientific meeting with the German Competent Authority responsible for cellular therapies – the Paul Ehrlich Institute [...]Comment
-
Just got an email from the Replicel newsletter:
That seems like a long time between end of Phase I and beginning of Phase II. They should have started by now.Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013 VANCOUVER, BC – November 7, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) is pleased to report on its pre-filing scientific meeting with the German Competent Authority responsible for cellular therapies – the Paul Ehrlich Institute [...]Comment
-
So that pushes Replicel out til mid-2014 to complete Phase II. They'd want to have some much more decent results than they got in Phase I by that time or they won't get funding for Phase III.Comment
-
Yup. And that's just for a dose ranging study. They'd probably need even another phase II efficacy study once they have the dose dialed in.
These guys are 5+ years out. And that's assuming they even have something that works, which i have some serious doubts about. I'm taking them off my radar. Put them in the bin with follica and acell.Comment
-
Dates available if all goes well...
Aderans = crap
Acell = crap
Histogen = 2018
Replicel = 2017
Allergan Bimatoprost = 2017
The EndComment
-
Really depressing to hear about them starting next summer - they should have geared up for a January start - 6 months is a long time.Comment
-
Same here - the only hope for me is some kind of cell therapy coming out - because I doubt PGD2 will be able to treat a NW5 patient.
Really dissapointed about the start date of Replicel, I'm happy that they've been approved to continue their study but just the time is becoming a real issue now.. I mean how many more years do we need to wait for a better treatment?Comment
-
UK, you mind if i ask your age? Would you consider a hair transplant?
The waiting around is killing me. And the more results that come out, the further away we seem to a solution. I thought 2012 was going to be the year when we find out for sure what's cooking and whether there is reason to have hope. But, 2012 is nearly up and things are as bleak as ever - replicel looks less than promising, histogen's results numerically look good but photos are not impressive, aderans continues to be a mystery, follica seems to have dropped out, and acell was a total bust. Could use some good news already.Comment
-
Can you wait until 2017-2018 when a superior treatment will be available? If not, consider a hair transplant.
Sorry, but its the truth.Comment
-
Yeah it sucks. I'm also annoyed they have apparently scratched their 12 month results analysis. Histogen had MUCH better results at 12 months over 6. But we have no way of knowing whether Replicel will too.
It may be an admission that the trial effectively failed, considering also all the extra work they've done tinkering with the process. But who knows.Comment
Comment